25 Years of Trastuzumab: A Legacy of Innovation
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
Tag: FDA
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report today. The report serves as an important record of the...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...